Yousif Capital Management’s Harmony Biosciences HRMY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$394K Buy
10,827
+39
+0.4% +$1.23K ﹤0.01% 1420
2026
Q1
$302K Sell
10,788
-95
-0.9% -$3.12K ﹤0.01% 1613
2025
Q4
$391K Sell
10,883
-1,534
-12% -$50.4K ﹤0.01% 1531
2025
Q3
$342K Sell
12,417
-1,963
-14% -$67.6K ﹤0.01% 1578
2025
Q2
$454K Buy
14,380
+13
+0.1% +$418 ﹤0.01% 1501
2025
Q1
$477K Buy
14,367
+42
+0.3% +$1.51K 0.01% 1449
2024
Q4
$493K Buy
14,325
+2,622
+22% +$90.1K 0.01% 1483
2024
Q3
$468K Sell
11,703
-1,209
-9% -$42.5K 0.01% 1524
2024
Q2
$390K Sell
12,912
-2,041
-14% -$61.4K ﹤0.01% 1583
2024
Q1
$502K Sell
14,953
-1,405
-9% -$45.1K 0.01% 1511
2023
Q4
$528K Sell
16,358
-325
-2% -$9.07K 0.01% 1504
2023
Q3
$547K Buy
16,683
+721
+5% +$25K 0.01% 1439
2023
Q2
$562K Sell
15,962
-831
-5% -$28.7K 0.01% 1443
2023
Q1
$548K Sell
16,793
-2,200
-12% -$100K 0.01% 1449
2022
Q4
$1.05M Sell
18,993
-4,890
-20% -$269K 0.01% 1133
2022
Q3
$1.06M Buy
23,883
+4,944
+26% +$241K 0.02% 1165
2022
Q2
$924K Sell
18,939
-1,940
-9% -$87.3K 0.01% 1278
2022
Q1
$1.02M Buy
20,879
+710
+4% +$29K 0.01% 1350
2021
Q4
$860K Buy
+20,169
New +$804K 0.01% 1432

Other funds holding HRMY

Yousif Capital Management's HRMY Position: Q2 2026 in Review

Yousif Capital Management increased its Harmony Biosciences (HRMY) stake by 0.36% in Q2 2026, buying an estimated $1.23K and bringing the position to 10,827 shares worth $394K. The position accounts for ﹤0.01% of the portfolio, ranked #1420.

Yousif Capital Management first reported a position in HRMY in Q4 2021 and has held it in 19 quarters since. The position peaked at $1.06M in Q3 2022. 327 funds tracked by Wall St. Rank hold HRMY as of Q2 2026.

  • Yousif Capital Management held 10,827 shares of Harmony Biosciences worth $394K as of Q2 2026.
  • Yousif Capital Management bought 39 Harmony Biosciences shares in Q2 2026, an estimated $1.23K.
  • Harmony Biosciences made up ﹤0.01% of Yousif Capital Management's portfolio in Q2 2026, its #1420 holding.
  • Yousif Capital Management first reported a position in Harmony Biosciences in Q4 2021 and has held it in 19 quarters since.
  • Yousif Capital Management's Harmony Biosciences position peaked at $1.06M in Q3 2022.
  • 327 funds tracked by Wall St. Rank held Harmony Biosciences as of Q2 2026.

Based on Yousif Capital Management's 13F filing for Q2 2026, filed 16 Jul 2026.